Cargando…

Effect of Dual Endothelin Receptor Antagonist on a Retinal Degeneration Animal Model by Regulating Choroidal Microvascular Morphology

OBJECTIVE: Clinical studies have found that increasing levels of plasma endothelin-1 (ET-1) might inhibit choroidal blood flow (BF) and promote choroidal vasoconstriction. This study was designed to investigate ET-1 levels and its effect on choroidal microvascular morphology in a retinitis pigmentos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiaowei, Lin, Xuming, Xu, Ying, Li, Naiyang, Zhou, Qing, Sun, Xiaowei, Li, Yuanbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626175/ https://www.ncbi.nlm.nih.gov/pubmed/34840823 http://dx.doi.org/10.1155/2021/5688300

Ejemplares similares

Ferulic acid attenuates microglia-mediated neuroinflammation in retinal degeneration
por: Sun, Xiaowei, et al.
Publicado: (2021)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Endothelin and Endothelin Antagonists in Chronic Kidney Disease
por: Kohan, Donald E., et al.
Publicado: (2014)

The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
por: Kowalczyk, Agata, et al.
Publicado: (2014)

Endothelin Receptor Antagonists in Kidney Disease
por: Martínez-Díaz, Irene, et al.
Publicado: (2023)

Correlation of retinal and choroidal microvascular impairment in systemic sclerosis
por: Rommel, Felix, et al.
Publicado: (2021)

Efficacy and safety of the endothelin-1 receptor antagonist macitentan in epicardial and microvascular vasospasm; a proof-of-concept study
por: Feenstra, Rutger G.T., et al.
Publicado: (2023)

Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension
por: Verweij, Pierre, et al.
Publicado: (2020)

Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
por: Angeli, Fabio, et al.
Publicado: (2021)

Antidiuretic Effects of the Endothelin Receptor Antagonist Avosentan
por: Baltatu, Ovidiu Constantin, et al.
Publicado: (2012)

Iontophoresis of Endothelin Receptor Antagonists in Rats and Men
por: Roustit, Matthieu, et al.
Publicado: (2012)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Quantitative analysis of retinal and choroidal microvascular changes in patients with diabetes
por: Kim, Mirinae, et al.
Publicado: (2018)

Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist
por: Bruderer, Shirin, et al.
Publicado: (2011)

Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience
por: Belge, Catharina, et al.
Publicado: (2019)

The importance of endothelin-1 for microvascular dysfunction in diabetes
por: Kalani, Majid
Publicado: (2008)

Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
por: Sidharta, P. N., et al.
Publicado: (2015)

Retinal microvascular abnormalities overlying choroidal nodules in neurofibromatosis type 1
por: Abdolrahimzadeh, Solmaz, et al.
Publicado: (2014)

An update on choroidal abnormalities and retinal microvascular changes in neurofibromatosis type 1
por: Mallone, Fabiana, et al.
Publicado: (2022)

Choroidal microvascular proliferation secondary to diabetes mellitus
por: Hua, Rui, et al.
Publicado: (2016)

Determination of the endothelin-1 recognition sites of endothelin receptor type A by the directed-degeneration method
por: Han, Seong-Gu, et al.
Publicado: (2017)

Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study
por: Abraham, George R., et al.
Publicado: (2022)

Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
por: Fontes, Magda S. C., et al.
Publicado: (2022)

Combining retinal and choroidal microvascular metrics improves discriminative power for diabetic retinopathy
por: Tan, Bingyao, et al.
Publicado: (2023)

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
por: Droste, Annette S, et al.
Publicado: (2009)

Beyond Vasodilator: Anti-Apoptotic Effect of Endothelin Receptor Antagonist
por: Chang, Sung-A
Publicado: (2014)

Clinical and hemodynamic effect of endothelin receptor antagonists in Eisenmenger Syndrome
por: Yonas, Emir, et al.
Publicado: (2020)

The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection
por: Landázuri, Natalia, et al.
Publicado: (2021)

Endothelin antagonists in subarachnoid hemorrhage: what next?
por: Macdonald, R Loch
Publicado: (2012)

Long-Term Effects on Retinal Structure and Function in a Mouse Endothelin-1 Model of Retinal Ganglion Cell Degeneration
por: Lakshmanan, Yamunadevi, et al.
Publicado: (2023)

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction
por: Ford, Thomas J, et al.
Publicado: (2020)

Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report
por: Álvarez Reyes, Fátima, et al.
Publicado: (2011)

Vascular derived endothelin receptor A controls endothelin-induced retinal ganglion cell death
por: Marola, Olivia J., et al.
Publicado: (2022)

Retinal and choroidal microvascular characterization and density changes in different stages of diabetic retinopathy eyes
por: Wang, Hui, et al.
Publicado: (2023)

Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells
por: Peduto Eberl, L, et al.
Publicado: (2003)

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
por: Steiner, M Kathryn, et al.
Publicado: (2008)

Macitentan: entry-into-humans study with a new endothelin receptor antagonist
por: Sidharta, Patricia N., et al.
Publicado: (2011)

Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
por: Enevoldsen, Frederik C., et al.
Publicado: (2020)

Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?
por: Chung, Edmund Y. M., et al.
Publicado: (2022)

Retinal Cell Degeneration in Animal Models
por: Niwa, Masayuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pafchth1558vfnjjh2v8a0acmb